Durable remission in a patient with ERBB2-amplified recurrent mucinous ovarian carcinoma treated with Trastuzumab-Carboplatin-Paclitaxel

Patients with advanced stage or recurrent mucinous ovarian carcinoma exhibit poor response to standard platinum- and taxane-based chemotherapy and poor prognosis. We report a 29-year-old patient with recurrent ERBB2-amplified mucinous ovarian carcinoma (with expansile growth pattern at initial diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Neil, Alexander J., Muto, Michael G., Kolin, David L., Konstantinopoulos, Panagiotis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336730/
https://www.ncbi.nlm.nih.gov/pubmed/37449085
http://dx.doi.org/10.1016/j.gore.2023.101237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336730/
https://www.ncbi.nlm.nih.gov/pubmed/37449085
http://dx.doi.org/10.1016/j.gore.2023.101237

Ejemplares similares